T2 Biosystems, Inc. - Special Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by, and welcome to the T2 Biosystems Update Conference Call. (Operator Instructions)
It is now my pleasure to turn the call over to Zack Kubow of W2O Group. Please go ahead, sir.
Thank you, operator, and good morning, everyone. Thanks for joining us for the T2 Biosystems update conference call to discuss the company's new contract with BARDA and other recent news. Joining me on the call are Chairman and CEO, John McDonough; and Chief Financial Officer, John Sprague.
The executive team will open the call with some prepared remarks followed by a question-and-answer period.
I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products.
Forward-looking statements are based on estimates and assumptions as of today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |